[Question] how do you actually verify identity
The title is the whole question — how do you actually verify identity — but here is why I am asking.
Research-use-only material is not approved for human use. In this catalogue that covers essentially everything, which is why the board discusses material and analytics rather than outcomes.
Storage guidance that names a temperature, a state and a duration reflects actual stability work. Generic guidance usually reflects a template.
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
Corrections welcome, especially the pedantic ones. Pedantry is how this board earns its reputation.
best — the order this archive was captured in
Purity methods differ by compound class. A gradient and wavelength developed for one peptide will not necessarily resolve the relevant impurities of another.
Sent an unusual compound to VendorInvestigate because nobody on this site had ever posted one. 99.6% against a claimed 99.0%.
I would not treat catalogue breadth as a quality signal. It is a business decision, not an analytical one.
Careful — that is a claim about efficacy and there is essentially no human evidence behind it.
Agreed — identity first for anything off the well-travelled list. The purity number is meaningless until you know what it is pure of.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
Net peptide content accounts for counterion, water and residual solvent. On some of these compounds the gap between purity and net content is substantial and entirely honest.
Net peptide content accounts for counterion, water and residual solvent.
This is the rule for anything unusual. Identity before anything else.
catalogue depth is not the same as catalogue quality
What storage conditions did they specify?
Naming in this space is inconsistent. Several widely used names map to more than one molecule, so a catalogue number and a sequence beat a common name every time.
What reference standard was the assay run against?
Net peptide content on the certificate was well below the purity figure and both were honest. Chemistry, not deception.
Yes. Nothing in this catalogue is approved for human use and the board should keep saying so.
Has anyone here tested that compound at all?
Net peptide content on the certificate?
Independent result added to the log — there are very few on that compound.
Independent result added to the log — there are very few on that compound.
Agreed — and the naming problem is worse than most people here realise.
Storage conditions came back specific rather than generic when I asked. That told me somebody had actually done stability work.
handling and storage vary enormously across this catalogue
What lead time were you quoted for that line?
Asked for identity confirmation on an unusual line and got a mass spectrum with the theoretical mass alongside. That is the answer I now look for everywhere.
the sequence is the product, everything else is packaging
the sequence is the product, everything else is packaging
Disagreeing with this bit: handling for one compound does not transfer to another by default.
This. Asking what reference standard was used separates a real analytical claim from a plausible-looking one.
Confirmed the lead time in writing before ordering a made-to-order line. It was longer than the site suggested and entirely reasonable once explained.
identity before purity, every time, for anything unusual
Ordered under a name that turned out to cover two different molecules. Nobody’s fault but mine for not asking.
identity before purity, every time, for anything unusual
patient_labslip_log is right that a purity figure without a method is not comparable to one with a method.
- 1Naming in this space is inconsistent. Several widely used names map to more…8 comments in this branch · started by u/bence_ibarra